Sahlgrenska Academy / Sahlgrenska akademin >
Institute of Medicine / Institutionen för medicin >
Doctoral Theses / Doktorsavhandlingar Institutionen för medicin >

Health-Related Quality of Life and Growth Hormone Treatment

Please use this identifier to cite or link to this item:

Files in This Item:

File Description SizeFormat
gupea_2077_61685_3.pdfAbstract1577KbAdobe PDF
gupea_2077_61685_5.pdfThesis frame6160KbAdobe PDF
Title: Health-Related Quality of Life and Growth Hormone Treatment
Other Titles: Long-term follow-up studies of women with Turner Syndrome and women with osteoporosis
Authors: Krantz, Emily
Issue Date: 18-Nov-2019
University: University of Gothenburg. Sahlgrenska Academy
Institution: Inst of Medicine. Department of Internal Medicine and Clinical Nutrition
Parts of work: I.Amundson E, Wide Boman U, Barrenäs M-L, Bryman I, Landin- Wilhelmsen K. Impact of Growth Hormone Therapy on Quality of Life in Adults with Turner Syndrome. J Clin Endocrinol Metab. 2010;95(3):1355-9

II.Krantz E, Landin-Wilhelmsen K, Trimpou P, Bryman I, Wide, U. Health-Related Quality of Life of Adult Women with Turner Syndrome and the Influence of Growth Promoting Therapy: A 20-year Follow-up. J Clin Endocrinol Metab. 2019;104(11):5073-83

III. Krantz E, Trimpou P, Landin-Wilhelmsen K. Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-year Follow-up Study. J Clin Endocrinol Metab. 2015;100(9):3251-9

IV. Krantz, E, Wide U, Trimpou P, Bryman I, Landin-Wilhelmsen K. Comparison Between Different Instruments for Measuring Health- Related Quality of life in a Population Sample, the WHO MONICA Project, Gothenburg, Sweden – an Observational, Cross-Sectional Study. BMJ Open. 2019;9:e24454

Date of Defence: 2019-12-13
Disputation: Fredagen den 13 december 2019, kl. 9.00, Hörsal Arvid Carlsson, Academicum, Medicinaregatan 3, Göteborg
Degree: Doctor of Philosophy (Medicine)
Publication type: Doctoral thesis
Keywords: Health-related Quality of Life
Growth hormone
Turner syndrome
Postmenopausal osteoporosis
Abstract: Introduction Growth Hormone (GH) is used to increase height in Turner Syndrome (TS), the most common sex-chromosome aberration in women. GH is also beneficial for bone mass. However, little is known about how GH treatment affects Health-Related Quality of Life (HRQoL). Aims To study if previous GH treatment for short stature in TS, and for strengthening bone in postmenopausal osteoporosis, leads to an improved HRQoL and to compare HRQoL to that of women in the general population. Methods HRQ... more
ISBN: 978-91-7833-578-7 (PRINT)
978-91-7833-579-4 (PDF)
Appears in Collections:Doctoral Theses from Sahlgrenska Academy
Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
Doctoral Theses / Doktorsavhandlingar Institutionen för medicin



© Göteborgs universitet 2011